Digest Network Come funziona
Network
/
Società
TR
Non verificato

TRIANA Biomedicines, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOncologiaSalute

3 comunicati stampa

Guarda tutti i comunicati
25/03/2026
Industria
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Igiene alimentare
Medicina - Varie
TRIANA Biomedicines’ TRI-611 Granted U.S. FDA Fast Track Designation for Treatment of ALK Positive Non-small Cell Lung Cancer
Fonte
TRIANA Biomedicines, Inc.
Emittente
Business Wire
1.00
0
19/03/2026
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
TRIANA Biomedicines Announces First Patient Dosed in a Phase 1/2 Trial Evaluating TRI-611 for the Treatment of ALK Positive Non-small Cell Lung Cancer
Fonte
TRIANA Biomedicines, Inc.
Emittente
Business Wire
1.00
0
03/12/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
TRIANA Biomedicines Announces Oversubscribed $120M Series B Financing to Advance its Molecular Glue Degrader Pipeline
Fonte
TRIANA Biomedicines, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0